...
首页> 外文期刊>American Journal of Neuroradiology >Combination of Single-Voxel Proton MR Spectroscopy and Apparent Diffusion Coefficient Calculation in the Evaluation of Common Brain Tumors
【24h】

Combination of Single-Voxel Proton MR Spectroscopy and Apparent Diffusion Coefficient Calculation in the Evaluation of Common Brain Tumors

机译:单体素质子磁共振波谱与表观扩散系数计算相结合评估常见脑肿瘤

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND PURPOSE: MR spectroscopy and apparent diffusion coefficient (ADC) calculation have been used frequently for tumor grading and differentiation during the last decade. We evaluated whether the combination of these two techniques can improve the diagnostic effectiveness of MR imaging in patients with brain tumors. METHODS: Forty-nine patients with histologically proved brain tumors (eight high- and 12 low-grade astrocytomas, eight metastases, eight nonastrocytic gliomas, seven meningiomas, three dysembryoplastic neuroepithelial tumors (DNETs), and three tuberculomas) were prospectively evaluated with contrast material–enhanced MR imaging, single-voxel proton MR spectroscopy (TE = 135 ms), and diffusion-weighted imaging (b = 0, 500, and 1000 s/mm2) before surgery. RESULTS: MR spectroscopy could differentiate benign from malignant tumors but was not useful in grading malignant tumors. In the differentiation of malignant from benign tumors, N-acetylaspartate (NAA)/choline (Cho), NAA/Cho + creatine (Cr), lactate/Cr, and alanin/Cr ratios (P < .001) were statistically more significant than NAA/Cr and lactate/lipid ratios (P < .05). Increase in lipid/Cr and alanin/Cr ratios could distinguish metastasis and meningiomas from other tumors, respectively (P < .001). DNETs could be diagnosed by their normal spectra and high ADC values (116.25 ± 6.93 x 10-3 mm2/s). Increase in lactate/Cr ratio correlated with degree of malignancy (r = -0.71). ADCs were effective for grading malignant tumors (P < .001) but not for distinguishing different tumor types with the same grade. High-grade malignant tumors (87.16 ± 10.41 x 10-3 mm2/s) had significantly lower ADC values than did low-grade malignant (115.33 ± 11.67 x 10-3 mm2/s) and benign (107.69 ± 8.05 x 10-3 mm2/s) tumors. Peritumoral ADCs were significantly higher in low-grade than in high-grade astrocytomas (P sup> .05). CONCLUSION: Combination of calculated ADC values from tumoral core and specific relative metabolite ratios acquired by MR spectroscopy added more information to MR imaging in the differentiation and grading of brain tumors and were more useful together than each alone.
机译:背景与目的:在过去的十年中,MR光谱学和表观扩散系数被广泛用于肿瘤的分级和鉴别。我们 评估了这两种技术的结合是否可以 提高磁共振成像对脑肿瘤患者的诊断效果。 >方法:49例经组织学证实为脑 肿瘤的患者(8个高级别和12个低度星形细胞瘤,8个转移灶, 8个非星形胶质细胞瘤,7个脑膜瘤,3个胚性增生<使用造影剂增强型 MR成像,单体素质子MR光谱法(TE = sup> )分别评估了sup> 神经上皮肿瘤(DNETs)和3例肺结核。 135毫秒), 和扩散加权成像(b = 0、500和1000 s / mm 2 结果:MR波谱可以区分良性和恶性肿瘤,但对恶性肿瘤分级无用。在 良性肿瘤的分化中,N-乙酰天门冬氨酸(NAA)/胆碱(Cho),NAA / Cho +肌酸(Cr),乳酸盐/ Cr和< sup> 丙氨酸/ Cr比(P <.001)在统计学上比NAA / Cr和乳酸/脂质比(P <.05)更显着。脂质/铬和丙氨酸/铬比值的增加 可以分别将转移性 和脑膜瘤与其他肿瘤区分开(P <.001)。 DNETs可以可以通过其正常光谱和高ADC 值(116.25±6.93 x 10 -3 mm 2 / s)进行诊断。乳酸/ Cr 比值的增加与恶性程度相关(r = -0.71)。 ADCs 对于恶性肿瘤分级有效(P <.001),但 对于区分相同等级的不同肿瘤类型无效。 高级恶性肿瘤(87.16±10.41 x 10 -3 mm 2 / s) 比低度恶性肿瘤 < /sup>(115.33±11.67 x 10 -3 mm 2 / s)和良性(107.69± 8.05 x 10 -3 mm 2 / s)肿瘤。结论:低度周界ADC明显高于高度星形细胞瘤(P sup> .05)。结论:计算出的ADC值的组合从MR 光谱学获得的肿瘤 核心和特定相对代谢物比率获得的信息为MR成像提供了有关脑肿瘤分化和分级的更多信息,并且更多比单独使用 有用。

著录项

  • 来源
    《American Journal of Neuroradiology》 |2003年第2期|225-233|共9页
  • 作者单位

    From the Department of Radiology, Gülhane Military Medical Academy, Ankara, Turkey;

    From the Department of Radiology, Gülhane Military Medical Academy, Ankara, Turkey;

    From the Department of Radiology, Gülhane Military Medical Academy, Ankara, Turkey;

    From the Department of Radiology, Gülhane Military Medical Academy, Ankara, Turkey;

    From the Department of Radiology, Gülhane Military Medical Academy, Ankara, Turkey;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号